Form 4: Director Thomas A. McCarthy Receives PRVA Equity Grant

Privia Health Group director Thomas A. McCarthy was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Summary

• Director Thomas A. McCarthy acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
• The grant was issued under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan.
• Following this transaction, the director's direct beneficial ownership increased to 27,983 shares of common stock.
• The director maintains an additional indirect holding of 41,487 shares held by a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential volatility in Privia Health Group's stock price.

Future Outlook

The restricted stock units are scheduled to vest on the earlier of the day before the 2027 annual meeting of stockholders or the first anniversary of the grant date.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the healthcare services sector.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices for mid-cap healthcare companies.
• The vesting schedule of approximately one year is aligned with typical annual equity grant cycles for public company directors.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

• Vesting of the 8,463 restricted stock units by May 20, 2027, or the 2027 annual meeting of stockholders.

Key Dates

Keywords

Privia Health Group, PRVA, Form 4, Insider Trading, Equity Compensation, Director Ownership